Abstract
PurposeWe investigated the influence of beam modulation on treatment planning by comparing four available stereotactic radiosurgery (SRS) modalities: Gamma-Knife-Perfexion, Novalis-Tx Dynamic-Conformal-Arc (DCA) and Dynamic-Multileaf-Collimation-Intensity-Modulated-radiotherapy (DMLC-IMRT), and Cyberknife. Material and methodsPatients with arteriovenous malformation (n=10) or acoustic neuromas (n=5) were planned with different treatment modalities. Paddick conformity index (CI), dose heterogeneity (DH), gradient index (GI) and beam-on time were used as dosimetric indices. ResultsGamma-Knife-Perfexion can achieve high degree of conformity (CI=0.77±0.04) with limited low-doses (GI=2.59±0.10) surrounding the inhomogeneous dose distribution (DH=0.84±0.05) at the cost of treatment time (68.1min±27.5). Novalis-Tx-DCA improved this inhomogeneity (DH=0.30±0.03) and treatment time (16.8min±2.2) at the cost of conformity (CI=0.66±0.04) and Novalis-TX-DMLC-IMRT improved the DCA CI (CI=0.68±0.04) and inhomogeneity (DH=0.18±0.05) at the cost of low-doses (GI=3.94±0.92) and treatment time (21.7min±3.4) (p<0.01). Cyberknife achieved comparable conformity (CI=0.77±0.06) at the cost of low-doses (GI=3.48±0.47) surrounding the homogeneous (DH=0.22±0.02) dose distribution and treatment time (28.4min±8.1) (p<0.01). ConclusionsGamma-Knife-Perfexion will comply with all SRS constraints (high conformity while minimizing low-dose spread). Multiple focal entries (Gamma-Knife-Perfexion and Cyberknife) will achieve better conformity than High-Definition-MLC of Novalis-Tx at the cost of treatment time. Non-isocentric beams (Cyberknife) or IMRT-beams (Novalis-Tx-DMLC-IMRT) will spread more low-dose than multiple isocenters (Gamma-Knife-Perfexion) or dynamic arcs (Novalis-Tx-DCA). Inverse planning and modulated fluences (Novalis-Tx-DMLC-IMRT and CyberKnife) will deliver the most homogeneous treatment. Furthermore, Linac-based systems (Novalis and Cyberknife) can perform image verification at the time of treatment delivery.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.